you are here:
Success
Alert
Please select a Day.
Info
71.75
-0.35 (-0.49%)

As on 20 Apr, 2021 | 03:48

Trade
Day Range
70.90
75.70
L H
52 Week Range
22.30
77.75
L H
Volume
141,786
*
i

* BSE Market Depth (20 Apr 2021)

BUY SELL
QTY PRICE PRICE QTY
50 71.25 72.70 80
1000 70.25 73.25 125
50 70.15 73.30 50
100 69.30 73.65 85
140 69.10 74.00 100
190 Total Total 500
Bid / Ask
71.25 / 72.70
71.40
-0.60 (-0.83%)

As on 20 Apr, 2021 | 03:40

Day Range
71.00
75.60
L H
52 Week Range
19.00
77.70
L H
Volume
18,163
*
i

* BSE Market Depth (20 Apr 2021)

BUY SELL
QTY PRICE PRICE QTY
50 71.25 72.70 80
1000 70.25 73.25 125
50 70.15 73.30 50
100 69.30 73.65 85
140 69.10 74.00 100
190 Total Total 500
Bid / Ask
71.25 / 72.70
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open75.50
          Previous Close72.10
          UC Limit75.70
          LC Limit68.50
          Volume141,786.00
          VWAP74.39
          Mkt Cap (Rs. Cr.)177
          20D Avg Volume66,035
          20D Avg Delivery37,251
          Beta0.170.23
          Face Value10.00
          TTM EPS--
          TTM PE--
          Sector PE41.36
          Book Value Per Share--
          P/B0.00
          Dividend Yield0.00
          P/C--

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Mid range performer: Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest.

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 206.62% away from 52 week low
          • 7.72% away from 52 week high
          • Outperformer - Brooks Laboratories up by 29.75% v/s NIFTY 50 down by -3.04% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          3

          indicates Weak Financials

          3 year CAGR growth
          Revenue 6.7%
          NetProfit %
          OperatingProfit %
          Industry Comparison
          • TTM PE Ratio - Negative PE Trailing 12M
          • Market Cap - Below industry Median
          • Price to Book Ratio - Below industry Median
          • TTM PEG Ratio - Above industry Median
          Shareholding Pattern
          • Promoters holding remains unchanged at 66.41% in Mar 2021 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          Forum

          Community Sentiments

          Data not Available

          What's your call on today?

          Read 1 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.
          17 Feb, 2021

          RAMBABU VELDI

          Qty 213000 Price 57.45 % Traded 0.86
          17 Feb, 2021

          LAKSHMI GUTTIKONDA VARA

          Qty 213000 Price 57.45 % Traded 0.86
          31 Mar, 2020

          MANGLAM FINANCIAL SERVICES

          Qty 200000 Price 15.25 % Traded 0.81
          31 Mar, 2020

          CHETAN RASIKLAL SHAH

          Qty 200000 Price 15.25 % Traded 0.81
          24 Apr, 2018

          NAVY STOCK CONSULTANT PRIVATE LIMITED

          Qty 110091 Price 110.16 % Traded 0.45
          24 Apr, 2018

          NAVY STOCK CONSULTANT PRIVATE LIMITED

          Qty 130091 Price 112.34 % Traded 0.53
          02 Sep, 2016

          AJAY ASSET MANAGEMENT PRIVATE LIMITED

          Qty 107199 Price 121.69 % Traded 0.43
          02 Sep, 2016

          PRARTHANA JINESHKUMAR JAIN

          Qty 88832 Price 120 % Traded 0.36

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          Feb, 18, 2021

          Manmohan Lal Mahajan

          Directors Immediate Relative
          Qty 822400 Price 0 % Traded 3.33 Post Tnx Hold. 0%
          Feb, 18, 2021

          Aryan Mahajan

          Directors Immediate Relative
          Qty 309280 Price 0 % Traded 1.25 Post Tnx Hold. 4.6%
          Feb, 18, 2021

          Erwin Mahajan

          Directors Immediate Relative
          Qty 513120 Price 0 % Traded 2.08 Post Tnx Hold. 4.6%
          Jul, 03, 2020

          Atul Ranchal

          Promoter
          Qty 2150000 Price 20 % Traded 12.62 Post Tnx Hold. 25.35%
          Jul, 03, 2020

          Rajesh Mahajan

          Promoter
          Qty 1621000 Price 20 % Traded 9.51 Post Tnx Hold. 20.7%
          Jul, 03, 2020

          Rajni Ranchal

          Promoter Group
          Qty 320000 Price 20 % Traded 1.88 Post Tnx Hold. 3.49%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Feb, 17, 2021

          Aryan Mahajan

          Promoter
          Qty 309280 Price 0 % Traded 1.25 Post Tnx Hold. 4.6%
          Feb, 17, 2021

          Manmohan Lal Mahajan

          Promoter
          Qty 822400 Price 0 % Traded 3.33 Post Tnx Hold. 0%
          Feb, 17, 2021

          Erwin Mahajan

          Promoter
          Qty 513120 Price 0 % Traded 2.08 Post Tnx Hold. 4.6%
          Jul, 02, 2020

          Rajesh Mahajan & PACs

          Promoter
          Qty 5744300 Price 0 % Traded 23.25 Post Tnx Hold. 66.41%
          Jul, 30, 2019

          Saras Gupta

          Promoter
          Qty 212500 Price 0 % Traded 1.31 Post Tnx Hold. 3.12%
          Jul, 10, 2019

          Aryan Mahajan

          Promoter
          Qty 212500 Price 0 % Traded 1.26 Post Tnx Hold. 3.13%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          Insights

          No Data For Institutional Holder Analysis.

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Brooks Labs 71.75 -0.49 177.24 - 1.80 -24.76 191.67 -24 69 0.24
          Sun Pharma 645.15 0.70 154793.10 60.41 3.15 8.31 36.28 4,186 32,837 0.17
          Divis Labs 3779.70 -0.72 100339.16 53.64 13.73 18.83 61.35 1,376 5,394 0.00
          Dr Reddys Labs 5156.75 3.80 85757.39 39.42 5.50 12.98 34.12 1,969 17,517 0.11
          Cipla 949.30 0.32 76557.56 34.22 4.78 9.81 62.16 1,546 17,131 0.18

          About the Company

          Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets. As of March 31, 2010, its product portfolio consist of 26 dry powder injections, 31 liquid injections, five tablets and two dry syrups. It manufactures a range of products on third party basis for companies, such as Zydus Cadila, Alembic, Intas, Wockhardt, Medley, Biochem, JB Chemical, PDPL and Sanat. Brooks Laboratories has a range of products catering to critical care segment in parental section, such as Beta Lactum, Cephalosporin, Carbapenems, General Dry powder Injectables and Liquid Injectables. Its Carbapenems products include Inj Ertapenem and Inj Meropenem. Its Liquid Injectables include Inj Nandrolone Decanoate, Inj Aceclofenac and Inj Midazolam.
          {"success":1,"data":{"address":{"address1":"Unit 1:","address2":"Village Kishanpura,.,Nalagarh Road,","city":"Solan District","state":"Himachal Pradesh","pincode":"174101","telephone1":"01795-654001","telephone2":"01795-654004","fax1":"01795-236939","fax2":"","email":"investors@brookslabs.net","web":"http:\/\/www.brookslabs.net"},"management":[{"name":"Atul Ranchal","designation":"Chairman"},{"name":"Rajesh Mahajan","designation":"Managing Director"},{"name":"Suresh Garg","designation":"Director - Technical"},{"name":"Rajnish Kumar Bedi","designation":"Independent Director"},{"name":"Deepak Mahajan","designation":"Independent Director"}],"registrars":{"name":"Link Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"533543","nseId":"BROOKS","series":"EQ","isinid":"INE650L01011"}}}
          • Registered Office

          • Registrars

          • Management

            • Atul Ranchal

              Chairman

            • Rajesh Mahajan

              Managing Director

            • Suresh Garg

              Director - Technical

            • Rajnish Kumar Bedi

              Independent Director

            • Deepak Mahajan

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              533543

            • NSE:

              BROOKS

            • Series

              EQ

            • ISIN

              INE650L01011

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>